Validating the Use of Corifollitropin Alfa in Progestin-Primed Ovarian Stimulation Protocol on Normal and High Responders by Comparing with Conventional Antagonist Protocol: A Retrospective Study

Validating the Use of Corifollitropin Alfa in Progestin-Primed Ovarian Stimulation Protocol on Normal and High Responders by Comparing with Conventional Antagonist Protocol: A Retrospective Study

Our previous study showed a satisfactory reproductive outcome resulting from the patient-friendly ovarian stimulation protocol using long-acting follicle stimulation hormone (FSH) plus oral medroxyprogesterone acetate (MPA). The present retrospective study aims to compare the efficacy of the patient...

Full description

Bibliographic Details
Main Authors: Chen-Yu Huang, Guan-Yeu Chen, Miawh-Lirng Shieh, Hsin-Yang Li
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Life
Subjects:
progestin-primed ovarian stimulation (PPOS)
long-acting FSH
patient-friendly
antagonist
Online Access:https://www.mdpi.com/2075-1729/10/6/90

Internet

https://www.mdpi.com/2075-1729/10/6/90

Similar Items